These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2675112)

  • 1. Development of asexual erythrocytic malaria vaccines.
    Chulay JD
    Prog Clin Biol Res; 1989; 313():13-21. PubMed ID: 2675112
    [No Abstract]   [Full Text] [Related]  

  • 2. Cloning of asexual blood-stage antigens of Plasmodium falciparum.
    Coppel RL; Crewther PE; Favaloro JM; Stahl HD
    P N G Med J; 1986 Mar; 29(1):75-80. PubMed ID: 3463017
    [No Abstract]   [Full Text] [Related]  

  • 3. Research in malaria vaccines.
    Miller LH
    N Engl J Med; 1986 Sep; 315(10):640-1. PubMed ID: 3526149
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malaria vaccine research].
    Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for human malaria: epidemiological and immunological perspectives.
    Webster HK; Diggs CL; Ballou WR; Chulay JD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of asexual blood stage malaria vaccines.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.
    Heidrich HG
    Z Parasitenkd; 1986; 72(1):1-11. PubMed ID: 3515789
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Lupski JR
    N Engl J Med; 1987 Feb; 316(7):415. PubMed ID: 3100954
    [No Abstract]   [Full Text] [Related]  

  • 9. [The fight against malaria--chemotherapy and immunoprophylaxis. 2. Immunoprophylaxis].
    Wagner WH
    Arzneimittelforschung; 1986 Feb; 36(2):163-75. PubMed ID: 3083828
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
    Chirkov VP; Popov AF
    Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of key antigens of Plasmodium falciparum as vaccine candidates.
    Bushell GR; Cooper JA; Ingram LT; Schofield L; Saul A; Epping RJ; Chiu S; Jelacic S; Upcroft JA
    P N G Med J; 1986 Mar; 29(1):69-73. PubMed ID: 3529708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunology and molecular biology: targetting of a vaccine].
    Perrin LH; Mach B
    Ther Umsch; 1986 Feb; 43(2):148-54. PubMed ID: 3515610
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of malaria vaccines.
    Perrin LH; Simitsek P; Srivastava I
    Trop Geogr Med; 1988 Jul; 40(3):S6-21. PubMed ID: 3055567
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane structure and function of malaria parasites and the infected erythrocyte.
    Sherman IW
    Parasitology; 1985 Dec; 91 ( Pt 3)():609-45. PubMed ID: 2867515
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
    Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can malaria be eradicated by vaccination?].
    Stürchler D
    Schweiz Rundsch Med Prax; 1987 Sep; 76(36):975-80. PubMed ID: 3310179
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-reacting antigens to Pc96, a protective antigen of Plasmodium chabaudi, in P. falciparum, P. vivax, and P. cynomolgi.
    Wanidworanun C; Barnwell JW; Nagasawa H; Aikawa M; Shear H
    Am J Trop Med Hyg; 1989 Jun; 40(6):579-84. PubMed ID: 2472747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
    Kinyanjui SM; Mwangi T; Bull PC; Newbold CI; Marsh K
    J Infect Dis; 2004 Nov; 190(9):1527-33. PubMed ID: 15478055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.